Anti-IgE (Omalizumab) in the treatment of uncontrolled severe asthmatic patients

被引:0
|
作者
Hinojosa, M. [1 ]
Huertas, B. [1 ]
Gonzalez-Cervera, J. [1 ]
Diez-Gomez, M. [1 ]
Sanchez-Cano, M. [1 ]
Pacheco, A. [1 ]
机构
[1] Hosp Ramon & Cajal, E-28034 Madrid, Spain
关键词
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:209 / 209
页数:1
相关论文
共 50 条
  • [21] Treating severe allergic asthma with anti-IgE monoclonal antibody (omalizumab): a review
    D'Amato, Gennaro
    Stanziola, Anna
    Sanduzzi, Alessandro
    Liccardi, Gennaro
    Salzillo, Antonello
    Vitale, Carolina
    Molino, Antonio
    Vatrella, Alessandro
    D'Amato, Maria
    MULTIDISCIPLINARY RESPIRATORY MEDICINE, 2014, 9
  • [22] Persistent severe egg allergy successfully responds to anti-IgE therapy (omalizumab)
    Huertas, B.
    Hinojosa, M.
    De la Hoz, B.
    Berges, P.
    Terrados, S.
    Pena, M.
    Alvarez-Cuesta, E.
    ALLERGY, 2010, 65 : 385 - 385
  • [23] Omalizumab (Xolair):: An anti-IgE antibody for asthma
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2003, 45 (1163): : 67 - 68
  • [24] Treatment of an asthmatic patient on dialysis and awaiting transplantation with anti-IgE
    Lafourcade, M. -P.
    Martin, M.
    Yver, L.
    REVUE DES MALADIES RESPIRATOIRES, 2008, 25 (07) : 857 - 860
  • [25] Anti-IgE Therapy with Omalizumab for Severe Asthma: Current Concepts and Potential Developments
    Pelaia, Girolamo
    Vatrella, Alessandro
    Busceti, Maria Teresa
    Gallelli, Luca
    Terracciano, Rosa
    Maselli, Rosario
    CURRENT DRUG TARGETS, 2015, 16 (02) : 171 - 178
  • [26] Anti-IgE (omalizumab) effective as atopic dermatitis treatment: A case series
    Rodriguez Rodriguez, M.
    Antolin Amerigo, D.
    Barbarroja, J.
    Mohedano Vicente, E.
    Perz Bustamante, M.
    ALLERGY, 2011, 66 : 618 - 618
  • [27] Analysis of asthma control and quality of life in severe allergic asthmatics under treatment with anti-IgE, omalizumab
    Pacheco-Galvan, Adalberto
    Hinojosa-Macias, Miguel
    Hurtado-Barbudo, Beatriz
    Gonzalez-Cervera, Jesus
    Sueiro-Bendito, Antonio
    MEDICINA CLINICA, 2009, 133 (12): : 460 - 463
  • [28] Anti-IgE monoclonal antibody, omalizumab: a new treatment for allergic asthma
    Chung, KF
    EXPERT OPINION ON PHARMACOTHERAPY, 2004, 5 (02) : 439 - 446
  • [29] Omalizumab (Xolair®) first anti-IgE antibody for treatment of poorly controlled severe persistent allergic asthma
    Pierre, Jacques
    PRESSE MEDICALE, 2007, 36 (03): : 444 - 444
  • [30] Efficacy Of The Anti-Ige Monoclonal Antibody Omalizumab In Patients With Severe Asthma Complicated With Eosinophilic Otitis Media
    Tagaya, E.
    Mizobuchi, R.
    Kubo, A.
    Hara, K.
    Takeyama, K.
    Kondo, M.
    Tamaoki, J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193